#1
Posted: Thu Feb 05, 2026 8:06 pm
Replacing animal testing with alternate methodologies in preclinical drug trials holds potential for the development of cheaper, safer pharmaceuticals as well as alleviating animal suffering. But according to a new paper co-written by a University of Illinois Urbana-Champaign expert in legal issues surrounding cutting-edge medical developments, such a novel approach to drug trials needs to be implemented judiciously and with caution.
Source: https://medicalxpress.com/news/2026-02- ... phase.html
Source: https://medicalxpress.com/news/2026-02- ... phase.html